SynthesisActa neurochirurgica2025
The association between allergy and risk of brain tumors: Evidence from 40 observational studies.
Synthesis in Acta neurochirurgica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
purposeThe potential association between the medical history of allergic conditions and brain tumors have been investigated. However, the agreement has not been reached. The aim of this meta-analysis was to explore the possible association between allergic disease and brain tumor risk.
methodsA comprehensive search was conducted and eligible studies were identified. Random-effects model was applied to meta-analyze the data.
resultsIn accordance with the retrieval strategy, 40 articles with 31 case-control studies and 9 cohort studies were enrolled in the present meta-analysis. The results suggested that history of allergy was associated with a decreased risk of brain tumor (OR 0.78, 95% CI 0.71-0.86). Compared to individuals with 1 allergic condition (OR 0.78, 95% CI 0.71-0.85), those with at least 2 allergic conditions (OR 0.65, 95% CI 0.58-0.73) may have a potentially lower brain tumor risk. Moreover, decreased brain tumor risk was found in both adults (OR 0.75, 95% CI 0.69-0.81) and children/adolescents (OR 0.78, 95% CI 0.62-0.97). Allergy history is associated with a decreased risk of glioma (OR 0.71. 95% CI 0.61-0.81). Besides, glioma risk is negatively associated with asthma (OR 0.82, 95% CI 0.74-0.91) and eczema (OR 0.84, 95% CI 0.72-0.98). There is a tendency that allergy is associated with decreased risk of meningioma (OR 0.89, 95% CI 0.74-1.07).
conclusionsAllergy should be considered as a protective factor for brain tumors, especially glioma. Further prospective cohort studies are needed to provide a higher level of evidence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.